Ad
related to: eli lilly stock close
Search results
Results from the WOW.Com Content Network
Shares of pharmaceutical stock Eli Lilly are cratering after the company lowered its sales guidance for Q4. ... As of market close on Jan. 15, Lilly stock is hovering near its lowest level in ...
Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same quarter in 2023.
The stock closed slightly higher, and Lilly ended the day with its market cap at just over $800 billion. The company has worked hard to end the shortage of its drugs, known by the key ingredient ...
In the first half of 2024, it seemed Eli Lilly (NYSE: LLY) could do no wrong. Is Eli Lilly a good stock to buy on the dip? On Jan. 14, CEO David Ricks told investors that 2024 sales would come in ...
Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been punished by investors. As of this writing, Lilly's stock price has plunged as ...
Here's what happened and why Eli Lilly stock is still worth buying. Expectations are too high. First, the bad news: Lilly slightly cut its guidance for 2024. Whereas it previously anticipated ...
The big pharma stock initially plunged close to 15% after the market opened on Thursday before bouncing back somewhat. Even with this partial rebound, Lilly's share price remains roughly 13% below ...
Eli Lilly (NYSE: LLY) may seem like an expensive stock to invest in right now. It's trading at close to 90 times its trailing earnings. It's trading at close to 90 times its trailing earnings.
Ad
related to: eli lilly stock close